Amylin

Results: 26



#Item
11Microwave Assisted Peptide Synthesis  Sanjukta Ghosh Green Chemistry – 671 December 8, 2011

Microwave Assisted Peptide Synthesis Sanjukta Ghosh Green Chemistry – 671 December 8, 2011

Add to Reading List

Source URL: alpha.chem.umb.edu

Language: English - Date: 2011-12-11 22:28:03
12SYMLIN® CRITERIA Pharmacology: Pramlintide is a synthetic analog of human amylin, a naturally occurring neuroendocrine hormone synthesized by pancreatic beta cells that contributes to glucose control during the postpran

SYMLIN® CRITERIA Pharmacology: Pramlintide is a synthetic analog of human amylin, a naturally occurring neuroendocrine hormone synthesized by pancreatic beta cells that contributes to glucose control during the postpran

Add to Reading List

Source URL: www.nhhealthyfamilies.com

Language: English - Date: 2014-09-11 16:48:56
13Microsoft Word - press release ADA.doc

Microsoft Word - press release ADA.doc

Add to Reading List

Source URL: www.analysisgroup.com

Language: English - Date: 2008-07-31 12:06:52
14Scientists show type-1 and type-2 diabetes are caused by same underlying mechanism

Scientists show type-1 and type-2 diabetes are caused by same underlying mechanism

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2014-11-26 11:32:40
15

PDF Document

Add to Reading List

Source URL: www.wiley-vch.de

Language: English - Date: 2011-07-27 21:04:49
16October 2007 IMPORTANT PRESCRIBING INFORMATION Dear Healthcare Professional: Amylin Pharmaceuticals, Inc. (Amylin) and Eli Lilly and Company (Lilly) wish to inform you of an important update to the Prescribing Informatio

October 2007 IMPORTANT PRESCRIBING INFORMATION Dear Healthcare Professional: Amylin Pharmaceuticals, Inc. (Amylin) and Eli Lilly and Company (Lilly) wish to inform you of an important update to the Prescribing Informatio

Add to Reading List

Source URL: www.fda.gov

Language: English
17October 2007 IMPORTANT PRESCRIBING INFORMATION Dear Healthcare Professional: Amylin Pharmaceuticals, Inc. (Amylin) and Eli Lilly and Company (Lilly) wish to inform you of an important update to the Prescribing Informatio

October 2007 IMPORTANT PRESCRIBING INFORMATION Dear Healthcare Professional: Amylin Pharmaceuticals, Inc. (Amylin) and Eli Lilly and Company (Lilly) wish to inform you of an important update to the Prescribing Informatio

Add to Reading List

Source URL: www.fda.gov

Language: English
18National Diabetes Information Clearinghouse  The Diabetes Dictionary  U.S. Department

National Diabetes Information Clearinghouse The Diabetes Dictionary U.S. Department

Add to Reading List

Source URL: diabetes.niddk.nih.gov

Language: English - Date: 2012-01-25 15:36:39
19NDA[removed]Initial REMS approval mm/yyyy BYDUREON™ (exenatide extended-release for injectable suspension) A glucogon-like peptide-1 (GLP-1) receptor agonist Amylin Pharmaceuticals, Inc. Contact: Sean Zhao, M.D., Ph.D.

NDA[removed]Initial REMS approval mm/yyyy BYDUREON™ (exenatide extended-release for injectable suspension) A glucogon-like peptide-1 (GLP-1) receptor agonist Amylin Pharmaceuticals, Inc. Contact: Sean Zhao, M.D., Ph.D.

Add to Reading List

Source URL: www.fda.gov

Language: English
20National Diabetes Information Clearinghouse  The Diabetes Dictionary  U.S. Department

National Diabetes Information Clearinghouse The Diabetes Dictionary U.S. Department

Add to Reading List

Source URL: diabetes.niddk.nih.gov

Language: English - Date: 2012-03-14 13:47:21